Skip to main content
Logo of Goethe university

A Turning Point in Modern Genetics

Davor Solter and Azim Surani receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2026

In 1984, a fundamental rule of genetics was overturned. Until then, it was considered certain: each of our body cells contains two active copies of every gene—one from the mother and one from the father. However, developmental biologists Davor Solter and Azim Surani demonstrated that this assumption isn’t always correct. Some genes are active in only a single parent-specific copy. Which copy is active is determined by a molecular marker in the genetic material. For their discovery of genomic imprinting, which fundamentally transformed our understanding of inheritance and development in mammals, the researchers will be honored in 2026 with the Paul Ehrlich and Ludwig Darmstaedter Prize.

Up until the early 1980s, the genetic regulations seemed straightforward. Inheritance was understood as a symmetrical process: every gene exists in duplicate, and both copies are utilized. This model had proven reliable and shaped generations of biologists. Yet, scientific progress often begins with seemingly minor questions. Solter and Surani encountered such a question when they—independently of each other—explored a fundamental distinction between mammals and other animal species.

AI-generated visual metaphor for genomic imprinting—a concept rooted in the work of the 2026 Paul Ehrlich and Ludwig Darmstaedter Prize laureates, Solter and Surani. (Image credit: Shahida, AI-generated)

AI-generated visual metaphor for genomic imprinting—a concept rooted in the work of the 2026 Paul Ehrlich and Ludwig Darmstaedter Prize laureates, Solter and Surani.

Shahida KI-generiert

A Mystery of Reproduction

Why is virgin birth not possible in mammals, as it is in bees or lizards? What prevents a mammalian egg cell from developing without a male contribution? This question was more than just a biological curiosity—it touched on the very essence of what defines mammals: the development of an embryo within the mother’s body.

To explore this, both researchers used a then-new experimental method. They transferred nuclei from germ cells to create mouse embryos containing either two female or two male nuclei. The result was clear—and unexpected. Not a single one of these embryos survived. Only in the control group, where a female and a male nucleus were combined, did the embryo develop normally. From this failure, the researchers drew a groundbreaking conclusion: In mammals, certain genes are activated exclusively by the mother, while others are activated exclusively by the father. They coined the term “genomic imprinting” to describe this biological principle, which explains why maternal and paternal genetic material are not equivalent and cannot be interchanged during development. This clarified how the system works, but the question of why remained unanswered. Why has this unequal treatment of parental genes persisted over the course of evolution?

An evolutionary balance of interests

Answers to these questions came from later studies. In 1991, researchers were able to identify specific imprinted genes for the first time. A clear pattern emerged: a growth-inhibiting gene is active only in its maternal copy, while a growth-promoting gene is active only in its paternal copy. This division is no coincidence. It reflects a biological balance of interests. The embryo has an "interest" in growing as quickly and robustly as possible. The mother, on the other hand, needs to protect her physical resources to stay healthy and potentially care for future offspring. Genomic imprinting ensures that neither of these interests dominates. Many researchers today believe that this finely tuned system was a prerequisite for the development of mammals with a uterus. However, one key question remained unanswered: How is this balance actually implemented within the cell? The answer doesn’t delve deeper into genetic engineering but instead points to a surprisingly simple idea.

The Paul Ehrlich and Ludwig Darmstaedter Prize is the most prestigious award for medical research in Germany, with a prize amount of €120,000. It is traditionally presented on March 14, Paul Ehrlich’s birthday, at the Paulskirche in Frankfurt.

The prize is managed by the Paul Ehrlich Foundation, which operates as a legally dependent foundation under the Association of Friends and Supporters of Goethe University. This commitment by the Friends and Supporters creates an environment where cutting-edge research in Frankfurt is showcased and receives public recognition.

Prof. Azim Surani (Photo credit: Azim Surani/Jaqueline Garget, University of Cambridge)

Prof. Davor Solter (Photo credit: Davor Solter, private)

Epigenetics: The Grammar of the Writing on Genes

Genomic imprinting does not alter the genetic blueprint itself. The sequence of genes remains the same. What’s decisive is something else: certain genes carry small chemical markings. These markings are added as early as in egg and sperm cells. They function like notes in the margins of a text, guiding the cell on which of the two available copies of a gene should be read—the maternal or the paternal one. The other copy remains silenced. With this discovery, Solter and Surani revealed an additional layer of inheritance. This layer operates not within the genes but above them. The concept of epigenetics emerged to describe this principle. It explains how genes can be switched on or off without changing the genetic text itself. What initially seemed like a special case in embryonic development soon proved to be a fundamental mechanism.

Significant medical importance

Genomic imprinting plays a role not only in early development but also in influencing growth, metabolism, and brain development. When this delicate interplay is thrown off balance, the consequences can be severe—such as misregulation during development and disruptions to key bodily functions. This is where the medical significance of epigenetics comes into focus: it highlights processes that operate quietly in the background long before a disease becomes apparent. In the case of diabetes, epigenetic changes can often be detected years before a diagnosis. Neurodegenerative diseases also exhibit characteristic epigenetic patterns. Many cancers carry these signatures well before a tumor forms. This shows that diseases don’t arise solely from altered genes but also from genes being active or inactive at the wrong time.

A true paradigm shift

From an elegant experiment that employed a new technique to answer a seemingly simple question, a profound transformation in the understanding of genetics emerged. The discovery of genomic imprinting fundamentally changed the way inheritance is understood—a true paradigm shift in every sense of the term. The recognition of Davor Solter and Azim Surani with the Paul Ehrlich and Ludwig Darmstaedter Prize in 2026 commemorates this pivotal moment 42 years ago. Their work provided a key to understanding embryonic development while simultaneously opening new avenues in disease research. This is precisely what the prize represents: honoring research that challenges certainties and permanently broadens our view of nature. It is awarded at a location that stands like few others for public engagement and responsibility—the Paulskirche in Frankfurt.

Author: Heike Jüngst

Turning Point in Modern Genetics | Goethe University